Latest News about BMY
Recent news which mentions BMY
10 Health Care Stocks Whale Activity In Today's Session
September 15, 2022
From Benzinga
Melanoma Study Achieves Key Milestone as Bristol's Flagship Treatment Secures Improvement in Survival Rates
September 15, 2022
Tickers
BMY
From Benzinga
These 5 Experts See A Market Crash Ahead: What Do BZ Readers Think?
September 14, 2022
From Benzinga
US Department Of Health, Defense To Inject $1B To Boost Domestic Biomanufacturing
September 14, 2022
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 14, 2022
September 14, 2022
From Benzinga
AstraZeneca, Eli Lilly and Roche among pharmaceutical companies upgraded for high returns on R&D investments, analysts say
September 14, 2022
From MarketWatch
US Stock Futures Rise After Recording Worst Sell-Off Since June 2020; PPI Data In Focus
September 14, 2022
From Benzinga
Biden Administration Pushes 'Cancer Moonshot' Initiative: Report
September 13, 2022
From Benzinga
10 Health Care Stocks Whale Activity In Today's Session
September 13, 2022
From Benzinga
7 Screaming Buy Stock Picks to Beat the September Market Slump
September 13, 2022
From InvestorPlace
Why Tuesday Morning Shares Tumbled 31%; Here Are 66 Biggest Movers From Yesterday
September 13, 2022
From Benzinga
NIO, Lucid Group And Other Big Gainers From Monday
September 13, 2022
From Benzinga
Why Clovis Oncology Zoomed 30% Higher Today
September 12, 2022
From Motley Fool
This Is What Whales Are Betting On Bristol-Myers Squibb
September 12, 2022
Tickers
BMY
From Benzinga
Why Ventyx Biosciences Is Trading Higher By 70%, Here Are 46 Stocks Moving In Monday's Mid-Day Session
September 12, 2022
From Benzinga
Bristol Myers Squibb Is a Must-Own Stock Right Now. Here's Why.
September 12, 2022
Tickers
BMY
From Motley Fool
QSR Stock Pops as Burger Kings Announces $400 Million Investment
September 12, 2022
From InvestorPlace
Adobe (ADBE) Stock Slips on Analyst Downgrade
September 12, 2022
From InvestorPlace
Buffett Still Loves Occidental, but Here's Monday's Mammoth Market Mover
September 12, 2022
From Motley Fool
From InvestorPlace
Here's Why Amgen Shares Are Diving
September 12, 2022
From Benzinga
HC Wainwright Cuts Price Target On This Stock By 73%, Also Check Out Other Major PT Changes Here
September 12, 2022
From Benzinga
Bristol-Myers Squibb, Carvana And Some Other Big Stocks Recording Gains In Today's Pre-Market Session
September 12, 2022
From Benzinga
From Benzinga
These three potential ‘naked swimmers’ threaten stocks and financial markets
September 12, 2022
From MarketWatch
Why Clovis Oncology Is Trading Higher By 14%; Here Are 28 Stocks Moving Premarket
September 12, 2022
From Benzinga
Bristol Myers' Deucravacitinib Scores FDA Approval For Plaque Psoriasis
September 12, 2022
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.